Metsera and Maze Therapeutics have become the second and third biotechs to complete an IPO on the Nasdaq this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback